Published Paper Details:

Cancer is caused by the uncontrolled growth of abnormal cells in the body, which is influenced by genetic and environmental factors. Some of the main factors that increase the risk of breast cancer are modern lifestyle changes, food choices, genetic vulnerability, family history, estrogen exposure, age, late night working, hazardous chemical exposure, obesity in the postmenopausal phase, and exposure to high doses of radiation. It is the most commonly diagnosed cancer and the leading cause of cancer deaths in women worldwide. Treatment and prevention of breast cancer are important issues in public health and medical practice. The current treatment strategy for this disease focuses on early detection and treatment. The current treatment strategy for this disease focuses on early detection and treatment. A literature study compiles and contrasts information on the clinical stages of breast cancer, wait times for treatment, and hurdles to access in various nations. It shows that while most high-income nations diagnose more than 70% of breast cancer patients in stages I and II, most low- and middle-income countries only diagnose 20% to 50% of patients in these earlier stages. New therapeutic approaches for breast cancer have been made possible by recent advancements in our understanding of the molecular and genetic changes underlying breast cancer's progression and development. According to the hypothesis, the result of novel treatment for breast cancer will emerge from identifying specific molecular targets that are exposed in research designed to illuminate the gene and molecules implicated in breast carcinogenesis. The fundamentals, pathophysiology, and classification of breast cancer are highlighted in this review, along with problems like multidrug resistance (by ABC transporter, P-glycoprotein, MDR-associated Protein (MRP1), breast cancer resistance protein (BCRP), drug resistance in breast cancer, and multidrug resistance in breast cancer cells in vitro), altered microtubules, altered enzyme, p-53 tumour suppressor gene, cell cycle, altered DNA repair processes, cell death response, and different types of It also covers potential and cutting-edge imaging methods for the treatment of breast cancer.